Page xvii

List of Tables and Figures

TABLES

2.1     Varieties of MS, 30
2.2     Initial Signs and Symptoms of MS, 32
2.3     Prognostic Relapse Indicators, 34
2.4     Information Provided by Neuroimaging, 38
2.5     Proposed CSF Disease Markers in MS, 44
2.6     Poser Diagnostic Criteria for MS, 46
2.7     MRI Criteria for Definite MS, 46
2.8     Evoked Potentials as a Diagnostic Tool in MS, 47
2.9     Disease-Modifying Therapies for Relapsing MS, 49
2.10     Clinical Pathological Correlations in Common Syndromes of MS, 62
2.11     Selected Diseases That Are Believed to Be Autoimmune Based, 69
2.12     Possible Autoantigens in MS, 71
2.13     CNS Demyelinating Diseases That Resemble MS, 85
2.14     Koch's Postulate on Causations of Disease by a Pathogen, 88
2.15     Agents Isolated or Implicated in the Etiology of MS, 89
2.16     Animal Models of MS, 91
2.17     Comparison Between Multiple Sclerosis and EAE, 92
2.18     Animal Viruses That Induce Demyelination, 96
3.1     Medications Used to Treat Depression, 124
3.2     Depression and Beta-Interferon, 126
3.3     Medications Used to Treat Spasticity, 134
3.4     Indications of Bladder Dysfunction, 141


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement